A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumoniaC. Avendaño, Rafael F. Duarte, Ilduara Pintos et al.|Journal of Clinical Investigation|2021Cited by 110
Convalescent Plasma for COVID-19: A multicenter, randomized clinical trialC. Avendaño, Mikel Mancheño‐Losa, Mayte Pérez‐Olmeda et al.|medRxiv|2020Cited by 108
Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19Roberto Lozano‐Rodríguez, Eduardo López‐Collazo, Marta Bergón-Gutiérrez et al.|Cell Reports|2021Cited by 51
Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS studyJavier García‐Pérez, Mayte Pérez‐Olmeda|EClinicalMedicine|2022Cited by 8